Statistical consideration for clinical biomarker research in bladder cancer Review uri icon

Overview

MeSH Major

  • Biomarkers
  • Urinary Bladder Neoplasms

abstract

  • Attention to sound design and statistical practice should be delivered as early as possible and will help maximize the promise of biomarkers for patient care. Studies should include a measure of predictive accuracy and clinical decision-analysis. External validation using data from an independent cohort provides the strongest evidence that a model is valid. There is a need for adequately assessed clinical biomarkers in bladder cancer.

publication date

  • July 2010

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC3407571

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2010.02.011

PubMed ID

  • 20610277

Additional Document Info

start page

  • 389

end page

  • 400

volume

  • 28

number

  • 4